E. E. Welshman

720 total citations
7 papers, 555 citations indexed

About

E. E. Welshman is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. E. Welshman has authored 7 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Genetics and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. E. Welshman's work include Cancer Treatment and Pharmacology (4 papers), Glioma Diagnosis and Treatment (2 papers) and Ethics in Clinical Research (1 paper). E. E. Welshman is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Glioma Diagnosis and Treatment (2 papers) and Ethics in Clinical Research (1 paper). E. E. Welshman collaborates with scholars based in United States. E. E. Welshman's co-authors include Elizabeth A. Calhoun, John R. Lurain, David A. Fishman, Thomas L. Hunt, David Cella, William A. Grobman, Charles L. Bennett, Chih‐Hung Chang, Sharon L. Dooley and Eugene Pergament and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and The Oncologist.

In The Last Decade

E. E. Welshman

7 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. E. Welshman United States	6	368	143	128	84	82	7	555
Moon Hee Lee South Korea	15	318 0.9×	21 0.1×	107 0.8×	140 1.7×	70 0.9×	67	654
Tunghi May Pini United States	5	347 0.9×	14 0.1×	55 0.4×	96 1.1×	81 1.0×	10	556
J Walczak United States	11	98 0.3×	25 0.2×	34 0.3×	144 1.7×	75 0.9×	25	528
Hye Jung Chang South Korea	14	275 0.7×	17 0.1×	32 0.3×	146 1.7×	21 0.3×	26	543
D B Thomas United States	11	336 0.9×	57 0.4×	11 0.1×	50 0.6×	49 0.6×	17	731
Arzu Yaren Türkiye	14	283 0.8×	25 0.2×	18 0.1×	138 1.6×	37 0.5×	51	550
Donal J. Sexton Ireland	15	63 0.2×	20 0.1×	39 0.3×	75 0.9×	103 1.3×	68	671
Moaath K. Mustafa Ali United States	12	127 0.3×	25 0.2×	117 0.9×	59 0.7×	39 0.5×	52	377
Katherine Dea United States	12	82 0.2×	36 0.3×	97 0.8×	84 1.0×	10 0.1×	20	502
Sara Ekberg Sweden	15	197 0.5×	15 0.1×	23 0.2×	85 1.0×	48 0.6×	50	514

Countries citing papers authored by E. E. Welshman

Since Specialization

Citations

This map shows the geographic impact of E. E. Welshman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. E. Welshman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. E. Welshman more than expected).

Fields of papers citing papers by E. E. Welshman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. E. Welshman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. E. Welshman. The network helps show where E. E. Welshman may publish in the future.

Co-authorship network of co-authors of E. E. Welshman

This figure shows the co-authorship network connecting the top 25 collaborators of E. E. Welshman. A scholar is included among the top collaborators of E. E. Welshman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. E. Welshman. E. E. Welshman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Welshman, E. E., et al.. (2005). Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex. Journal of Clinical Oncology. 23(16_suppl). 8044–8044. 4 indexed citations

Grobman, William A., E. E. Welshman, & Elizabeth A. Calhoun. (2004). Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial. American Journal of Obstetrics and Gynecology. 191(1). 235–240. 41 indexed citations

Calhoun, Elizabeth A., David A. Fishman, John R. Lurain, E. E. Welshman, & Charles L. Bennett. (2004). A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians. Gynecologic Oncology. 93(1). 164–169. 14 indexed citations

Calhoun, Elizabeth A., E. E. Welshman, John R. Lurain, et al.. (2003). Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecological Cancer. 13(6). 741–748. 298 indexed citations

Calhoun, Elizabeth A., E. E. Welshman, John R. Lurain, et al.. (2003). Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecological Cancer. 13(6). 741–748. 58 indexed citations

Grobman, William A., Sharon L. Dooley, E. E. Welshman, Eugene Pergament, & Elizabeth A. Calhoun. (2002). Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?. Prenatal Diagnosis. 22(13). 1195–1200. 52 indexed citations

Calhoun, Elizabeth A., Chih‐Hung Chang, E. E. Welshman, et al.. (2001). Evaluating the Total Costs of Chemotherapy-Induced Toxicity: Results from a Pilot Study with Ovarian Cancer Patients. The Oncologist. 6(5). 441–445. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact